An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Companies… Read More »Why half of all workers may struggle to get weight-loss drug health insurance coverage
My top 10 things to watch Friday, Nov. 3 1. U.S. stocks climb higher in premarket trading Friday, with S & P 500 futures up… Read More »Jim Cramer’s top 10 things to watch in the stock market Friday
Despite a downbeat month for stocks and mounting macroeconomic uncertainty, several Club names outperformed the market in October — and landed in the green. While… Read More »These 10 portfolio names outperformed the stock market amid the October decline
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in… Read More »Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Two weeks into the second half of the year, we put together a quick look at the top four performers and the bottom four in… Read More »Here are our top 4 stocks and worst 4 stocks to start the second half of 2023
Take a look at some of the biggest movers in the premarket: https://www.cnbc.com/quotes/LLY” target=”_blank” rel=”noopener”>Eli Lilly (LLY) – The drug maker’s stock fell 3.6% in… Read More »Stocks making the biggest moves premarket: Eli Lilly, Cigna, Restaurant Brands and more
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments.… Read More »3 takeaways from the Investing Club’s ‘Morning Meeting’ on Wednesday
